|Articles|September 15, 2002
- BioPharm International-09-01-2002
- Volume 15
- Issue 9
If a Tree Fell in the Forest
Author(s)Jim Miller
by Jim Miller, Bio/Pharmaceutical Outsourcing Report If a CRO or contract manufacturer was outperforming others in the industry, would anybody notice?
Advertisement
Articles in this issue
about 23 years ago
Reexamining the Set It and Forget It Approachabout 23 years ago
Security in the Corporate Homelandabout 23 years ago
Integrating New Technology into Blood Plasma Fractionationabout 23 years ago
Attack Mounts on Pharmaceutical PricesNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
Implications of the First Liquid IV Infliximab Biosimilar
2
GSK Bets $50M on LTZ’s Immune-Engager Platform for Next-Gen Cancer Treatment
3
Risks, Resource Strain, and Trade-Offs in FDA’s CNPV Pilot Program
4
Why 503B Compounding Pharmacies Choose Prefabricated POD® Cleanrooms
5
